From GlobeNewswire: 2024-12-13 09:05:00

The global Autoimmune Disease Therapeutics Market was valued at USD 72.34 Billion in 2023 and is projected to reach USD 116.81 Billion by 2032, with a CAGR of 5.52% from 2024 to 2032. Advances in biologics and biosimilars are revolutionizing treatment options for autoimmune disorders, driving market growth.

Innovations in artificial intelligence, precision medicine, and gene therapy are reshaping the Autoimmune Disease Therapeutics Market. The development of the EXPRESSO AI algorithm by Penn State promises to enhance prediction and treatment, while breakthroughs in gene therapy and delivery mechanisms are improving patient outcomes and quality of life.

Hospital pharmacies lead the market, capturing 54% of revenue share in 2023. Online stores are expected to grow at a CAGR of 8.04% from 2024 to 2032, driven by the shift towards e-commerce and telemedicine. Rheumatic diseases dominate the market, while the Inflammatory Bowel Disease segment shows rapid growth.

North America leads the Autoimmune Disease Therapeutics Market, holding 44% of revenue share in 2023. The Asia Pacific region is poised for rapid growth with a projected CAGR of 7.25% from 2024 to 2032, driven by increasing disease incidence and healthcare access in emerging economies.

Key developments include Bristol Myers Squibb advancing CAR T-cell therapy for lupus and multiple sclerosis, and Novartis reporting long-term benefits for RMS patients with Kesimpta. These advancements point towards a promising future for autoimmune disease treatment. The Autoimmune Disease Therapeutics Market Analysis & Outlook for 2024-2032 includes statistical insights on incidence, prevalence, prescription trends, drug volume, and healthcare spending. The report also covers competitive landscape, market segmentation by drug class type, indication, sales channel, regional analysis, company profiles, and use cases. Purchase options available for reports pack or subscription. SNS Insider provides accurate market data and insights for informed decision-making.



Read more at GlobeNewswire: Global Autoimmune Disease Therapeutics Market to Reach USD